Pills Equipped with Sensors to Digitally Track When and If You Took the Drug Approved by FDA in 2017

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @globalresearch_crg.

***

Pills with digital sensors are now the latest controversial technology that has seen itself gain approval from the FDA. The alarming new devices would employ a set of sensors within the chips to track data regarding each patients.

It has been revealed that the FDA has authorized an Orwellian medical device that utilizes sensors implanted into tablets to digitally monitor medicine intake in patients’ bodies.

The US Food and Treatment Administration bragged in a recently released press statement from December 2017 regarding certifying an unique medication with a “digital ingestion tracking system” that employs “sensors” within pills to interact with a mobile device to document if and when the patient ingested the medicines.

“The system works by sending a message from the pill’s sensor to a wearable patch,” according to a press release.

“The patch transmits the information to a mobile application so that patients can track the ingestion of the medication on their smart phone. Patients can also permit their caregivers and physician to access the information through a web-based portal.”

Abilify, an antipsychotic medicine utilized to treat major psychiatric diseases such schizophrenia and bipolar driven mania, has been authorized to use this technology. Nonetheless, the FDA cleared the application of the “ingestible sensor” in 2012, indicating that the innovation could be utilized more broadly in the future.

“Being able to track ingestion of medications prescribed for mental illness may be useful for some patients,” said Mitchell Mathis, M.D., director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research.

“The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers.”

It is hardly contentious to use medicine to ensure that individuals who may be a hazard to oneself or others are cared for properly. Those opposed to the existing COVID-19 vaccine regulations, on the other hand, will be concerned about whatever technology that could aid in the continuation of medical dictatorship.

According to Dr. Harvey Risch, an epidemiologist at Yale University, the COVID-19 pandemic was one of fear, manufactured by people in nominal positions of power as the virus spread around the world last year.

Melissa Ciummei, an Irish independent financial investor, believes that COVID Vaccine Passports will ultimately control your life right up to the point where a global social credit system is in place.

The leading doctor credited with improving early treatment of COVID-19 said in a conference that the goal of vaccine transmission campaigns is to “control and kill off a large proportion of our population without anyone suspecting that we were poisoned.”

“The deaths that are meant to follow the vaccinations will never be able to be pinned on the poison. They will be too diverse, there will be too many, and they will be in too broad a timeframe for us to understand that we have been poisoned,” claims Dr. Shankara Chetty.

Not many are aware that the Big Tech, Big Government, Big Pharma censorship of the truth about COVID-19 is actively coordinated by NATO’s war propaganda arm, the Atlantic Council. This is how the Atlantic Council pulled over the COVID-19 Matrix on the world.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from GGI


Articles by: Great Game India

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]